Dietary Modification In Inflammatory Bowel Disease Patients
Dietary Modification In Patients With Inflammatory Bowel Diseases And Its Impact In Gut Microbiome
1 other identifier
interventional
74
1 country
1
Brief Summary
This research project aimed to develop a culturally appropriate Asian Inflammatory Bowel Disease Diet for the Malaysian population, based on the Crohn's disease exclusion diet (CDED). The study will be conducted in inflammatory bowel disease patients in University Malaya Medical Centre, which are ulcerative colitis and Crohn's disease patients. The objectives of this study are to assess the impact of diet in clinical outcome and gut microbiota changes in patients with inflammatory bowel disease (IBD). The study duration spans 24 weeks, during which comprehensive follow-ups will be conducted at 0, 6, 12, and 24 weeks, respectively. At each follow-up session, participants will be requested to provide stool and blood samples for meticulous assessment of clinical and biochemical responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedFirst Posted
Study publicly available on registry
March 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 10, 2026
CompletedMay 31, 2025
May 1, 2025
6 months
February 24, 2025
May 27, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
To improve the Asian Inflammatory Bowel Disease diet.
Implementing improvised dietary guidance based on CDED is suitable for Asian settings to see patients' adherence (%) based on the diet adherence rating scale questionnaire.
24 weeks
Number of Participants Achieving Clinical Response at Week 12
Clinical response will be assessed based on Crohn's Disease Activity Index (CDAI) score. An improvement of clinical response is defined as \<150 CDAI score at week 12.
12 weeks
Secondary Outcomes (3)
Change in Fecal Calprotectin Concentration from Baseline to Post-Intervention
12 weeks
Changes in Gut Microbiota Composition Over Time (Baseline, Week 6, Week 12, Week 24)
Baseline, Week 6, Week 12, Week 24
Differential Distribution of Gut Microbiota Between Control and Intervention Groups at Weeks 6, 12, and 24
Week 6, Week 12, Week 24
Study Arms (2)
General Healthy Diet Group
ACTIVE COMPARATORParticipants in this group will follow the quarter-quarter-half plate diet based on the Malaysian Healthy Plate guideline.
Crohn's Disease Exclusion Diet (CDED) Group
EXPERIMENTALParticipants in this group will follow the Crohn's Disease Exclusion Diet (CDED), which consists of three phases with specific dietary restrictions.
Interventions
Participants will follow the quarter-quarter-half plate diet as per the Malaysian Healthy Plate guideline.
Participants will follow the Crohn's Disease Exclusion Diet (CDED), which consists of three phases with specific dietary restrictions.
Eligibility Criteria
You may qualify if:
- Confirmed diagnosis of Crohn's disease according to established clinical, endoscopic, and histological criteria.
- Mild to moderate diseases (150 to 220 points).
- Written informed consent obtained.
You may not qualify if:
- Presence of stoma.
- Surgery within 6 months prior to randomization.
- Patient on exclusive enteral nutrition (EEN).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universiti Malaya Medical Centre
Kuala Lumpur, Petaling Jaya, 50603, Malaysia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2025
First Posted
March 11, 2025
Study Start
March 1, 2025
Primary Completion
September 10, 2025
Study Completion
February 10, 2026
Last Updated
May 31, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share